Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Certain drugs not suitable for pharmacists' emergency shortage powers

It would be unsuitable for pharmacists to dispense alternatives to certain drugs under the upcoming shortages regulations, the NPA's director of pharmacy has confirmed.

The Human Medicines (Amendment) Regulations 2019 order – which is scheduled to come into force next week (February 9) – includes provisions to allow pharmacists to dispense an alternative in accordance with a “serious shortage protocol”, rather than the prescription, without contacting the GP, in the event of a national medicines shortage.

In its explanatory note published alongside the order, the Department of Health and Social Care (DH) stressed that “protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients”. It gave the examples of “epilepsy or treatments requiring biological products, where the medicines...need to be prescribed by brand for clinical reasons”.

“In these cases, patients would always be referred back to the prescriber for any decision about their treatment, before any therapeutic or generic equivalent is supplied,” the DH added.

Based on the DH’s guidance, National Pharmacy Association (NPA) director of pharmacy Leyla Hannbeck suggested other medicines that may not be covered by a “serious shortage protocol” could include “those with a narrow therapeutic index”, such as warfarin and methotrexate.

“Drugs that have to be brand-prescribed, or insulins with different strengths, may be difficult to substitute,” she told C+D last week (January 23).

It would also be “unsuitable” for pharmacists to dispense alternatives to “anti-rejection drugs used in transplant patients”, such as mycophenolate or ciclosporin, “certain modified-release preparations that are not interchangeable” and “controlled drugs, especially those in schedules 2, 3 and 4”, Ms Hannbeck said.

“Medicines where patient familiarity with a specific brand is important and instruction for use may vary between brands” may also be unsuitable for any DH protocol, she added.

“However, in the event of the complete unavailability of a medicine, the DH may choose to initiate a [protocol] for a medicine that would have previously been considered unsuitable, to ensure that affected patients are not left without medication,” she added.

While the sector awaits further details on how the protocols will work in practice, Ms Hannbeck said “it would be expected” that any patients receiving medicines under a protocol would be closely monitored.

The DH stressed earlier this month that “any protocol would be developed with and signed off centrally by clinicians” before it is implemented.

Medicines stockpiling ahead of Brexit

As the Guardian reports some patients are stockpiling medicines in fear of disrupted medicines supplies after Brexit, C+D wants to know if you've seen any evidence of this. Vote in C+D's poll below and contact us anonymously with more details at [email protected]

Result

Have you seen or heard any evidence of patients stockpiling medicines ahead of Brexit?
Yes
40%
No
60%
Total votes: 128

What do you make of the DH's "serious shortage protocols"?

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005725

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel